NEXMED
Medical calculator · educational

Wegovy Calculator (semaglutide)

Dose escalation schedule, BMI eligibility check and estimated weight loss for Wegovy (semaglutide 2.4 mg).

At a glance: Wegovy (semaglutide)

Active substance
semaglutide
Drug class
GLP-1 receptor agonist
How it is given
subcutaneous injection, once a week
Maintenance dose
2.4 mg
Dose escalation
16 weeks, 5 steps (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg)
Average weight loss
~14.9% at 68 weeks (STEP 1)

A strictly educational, indicative tool. It does not replace medical advice and does not give dosing instructions. Wegovy (semaglutide) is a prescription medicine: only the prescribing doctor decides eligibility and dose.

Weight-related conditions
Body mass index
32.9Obesity class I

Potentially eligible under EMA criteria

Indicative criteria: BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition. The final decision is your doctor's.

BMI does not distinguish muscle from fat and has limitations (athletes, older adults, pregnancy).

Data from the STEP 1 trial

In the STEP 1 trial (68 weeks), adults without diabetes treated with semaglutide 2.4 mg lost on average about 14.9% of their starting body weight, compared with about 2.4% on placebo.

About Wegovy treatment

How Wegovy works

Semaglutide is a GLP-1 receptor agonist: it mimics a gut hormone that is naturally released after eating. It acts on the appetite centres in the brain, reduces hunger, increases fullness and slows stomach emptying. In practice you eat less and feel full sooner, without the constant sense of restriction of a conventional diet.

How fast do you lose weight on Wegovy?

Weight loss is gradual rather than immediate: the first weeks are spent escalating the dose, and the effect grows as the dose increases. As a rough guide, based on the STEP 1 trial:

  • Weeks 1–4 (0.25 mg): little effect on weight while your body adjusts to the medicine.
  • About 5% of body weight: around weeks 16–20.
  • About 10%: around weeks 32–40.
  • About 15% (the average maximum): towards week 68 (around 16 months), on the 2.4 mg maintenance dose.
  • During the active phase, healthy weight loss is roughly 0.5–1 kg (1–2 lb) a week. The pace varies a lot from person to person.

What to expect during treatment

The most common side effects are digestive (nausea, bloating, constipation or diarrhoea), usually mild and temporary, especially when the dose goes up. Slow dose escalation, smaller meals and good hydration help. Tell your doctor if symptoms are severe or persistent, or if you have intense abdominal pain.

Nutrition matters as much as the medicine

These treatments reduce appetite, so you will eat less, which makes the quality of every meal even more important. A good diet prevents nutritional deficiencies, protects muscle mass and improves digestive tolerance. Ideally, your eating plan is put together with a doctor or registered dietitian, rather than simply eating smaller portions.

Protein: protect your muscle mass

With rapid weight loss there is a risk of losing muscle as well as fat. Eating enough protein, spread across every meal, helps preserve muscle and keeps you full for longer.

  • As a guide, about 1.2–1.6 g of protein per kg of ideal body weight per day (individualised by your doctor or dietitian).
  • Spread protein across every meal, not just dinner.
  • Good sources: eggs, lean meat, fish, dairy, legumes, tofu.
  • Combine it with strength training to maintain muscle.

Fibre: fullness, blood sugar and digestion

Fibre keeps you full for longer, softens blood sugar spikes and helps prevent constipation, a common side effect of these treatments.

  • Increase fibre gradually and drink enough water to avoid bloating.
  • Aim for about 25–30 g of fibre a day from a variety of foods.
  • Sources: vegetables, fruit, legumes, wholegrains, seeds.

Hydration and habits that reduce nausea

Drink water steadily throughout the day, since dehydration makes nausea and constipation worse. Choose small, frequent meals, eat slowly and stop at the first sign of fullness. Limit very fatty, fried and ultra-processed foods and concentrated sweets, as they make nausea worse. Keep alcohol moderate: it adds empty calories and irritates the stomach.

Keeping the weight off long term

Obesity is a chronic disease: when treatment stops, some of the weight often comes back because appetite returns. That is why Wegovy is used long term and combined with a balanced diet and physical activity for lasting results.

Who can use it

It is generally intended for adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition (type 2 diabetes, high blood pressure, sleep apnoea and others). It must not be used during pregnancy and has contraindications (for example a history of medullary thyroid carcinoma or MEN2 syndrome, or pancreatitis). Only your doctor can decide whether it is right for you and at what dose.

Wegovy: frequently asked questions

What is the Wegovy dose schedule?+

The standard schedule in the prescribing information increases the dose every 4 weeks: 0.25 mg (weeks 1–4), 0.5 mg (weeks 5–8), 1.0 mg (weeks 9–12), 1.7 mg (weeks 13–16), then the 2.4 mg maintenance dose from week 17. Your doctor may adjust the pace depending on how well you tolerate it.

How much weight can you lose on Wegovy?+

In the STEP 1 trial, average weight loss was about 14.9% of starting body weight at 68 weeks in adults without diabetes. Individual results vary.

What is the maximum dose of Wegovy?+

The maintenance and maximum dose for weight management is 2.4 mg, injected under the skin once a week.

Who is this calculator for?+

It is an educational tool for patients and healthcare professionals who want to understand the dose escalation schedule, the eligibility criteria and the average results seen in clinical trials. It is not a medical device and does not give personalised recommendations.

Are the projected results guaranteed?+

No. The figures are averages from clinical trials. Your individual result depends on diet, physical activity, adherence to treatment, dose and medical factors. Some people lose more weight, others less.

Why is gradual dose escalation important?+

Increasing the dose step by step reduces digestive side effects (nausea, vomiting, diarrhoea). Your doctor may slow the pace if you are not tolerating it well. Do not rush and do not skip steps.

Other calculators

Sources and limitations

The dose escalation schedule follows the summary of product characteristics (SmPC/EMA). Average results come from the STEP 1 trial. The eligibility criteria (BMI ≥ 30, or ≥ 27 with weight-related conditions) are indicative.

This calculator does not diagnose or prescribe treatment. For any medical decision, talk to your doctor and read the approved patient leaflet.EMA

Content last reviewed: 19 August 2026.